Delivery Order SPE2DB24D9113-SPE2DB25FEQCG
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Xtandi 40 mg tablets (120-count units). The contract, valued at $8,339.18 with a completion date of September 12, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract utilizes a firm fixed-price structure with no set-aside designation and is scheduled for completion by August 12, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Xtandi 40 mg tablets (120-count units) with a ceiling value of $8,339.18. This firm fixed-price delivery order, which is scheduled for completion by September 10, 2025, represents a tactical execution under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract ceiling value is $38,376.87, with an ultimate completion date of September 11, 2025. This delivery order carries no set-aside designation and represents a direct fulfillment order under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $8,622.72 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract, which carries no set-aside designation, is set for ultimate completion by September 4, 2025, and represents a delivery order issued under DMS Pharmaceutical Group's substantial Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Xtandi 80 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $4,169.59 with an ultimate completion date of July 28, 2025, was issued without a set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract, which carries no set-aside designation, is scheduled for completion by July 22, 2025, with performance at the vendor's Park Ridge location. This delivery order is issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency (DLA) on June 5, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract, which carries no set-aside designation, is scheduled for ultimate completion by June 6, 2025, with performance taking place at the vendor's Park Ridge facility. This delivery order was...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 30, 2025, for 120 tablets of Xtandi 40 mg with a ceiling value of $8,339.18. This firm fixed-price delivery order, which has an ultimate completion date of July 31, 2025, was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain. The award represents a single delivery order under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,311.35 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing...
- SPE2DB24D9113Indefinite Delivery Contract
- SPE2DB24D9113-SPE2DB25FEQCGDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Xtandi 40 mg tablets (120-count packages). The contract, valued at $8,339.18 with an ultimate completion date of August 6, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes firm fixed-price purchases for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. Xtandi, a prescription oncology medication used in the treatment of prostate cancer, represents the type of specialized pharmaceutical product within DMS Pharmaceutical Group's established portfolio of branded and generic prescription drugs supplied to Department of Defense healthcare sites. The company's positioning as a critical supplier in the federal pharmaceutical supply chain is demonstrated through its consistent award of delivery orders covering diverse medical products, from contraceptive devices to specialty medications and biologics, all distributed to support military healthcare operations nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/5/25 |